YU BAOFA has a total of 21 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2001. It filed its patents most often in China, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, environmental technology and thermal processes are MAREGADE RX LLC, FEBRIS BIO TECH LTD and EVELIQURE BIOTECHNOLOGIES GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 6 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Thermal processes |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Domestic heating systems |
# | Name | Total Patents |
---|---|---|
#1 | Yu Baofa | 20 |
#2 | Yu Shanwen | 2 |
#3 | Li Baihong | 2 |
#4 | Yu Liyang | 2 |
#5 | Song Zhenghua | 1 |
#6 | Jian Jin | 1 |
#7 | Li Zhongjun | 1 |
#8 | Wen Hong | 1 |
#9 | Yu Jichang | 1 |
#10 | Zhao Wenbin | 1 |
Publication | Filing date | Title |
---|---|---|
CN109340902A | A kind of adjustment type water stream injection pump is for heat balance system and its balance method | |
CN106813293A | Central heating system whole-network heat balance control method | |
WO2016086070A1 | Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy | |
WO2009121238A1 | A composition and method for auto-treating tumors | |
US2010104660A1 | Targeting cancer therapy combination | |
US7927612B2 | Combinations and methods for treating neoplasms | |
CN1562258A | Three-oxygen therapy ointment | |
CN1539477A | Method for making up Chinese materia medica preparation of cold decoct | |
US6811788B2 | Combinations and methods for treating neoplasms |